Study to Evaluate Vibegron on Patient Treatment Satisfaction Quality of Life and Healthcare Resource Utilization in Patients with Overactive Bladder

Brief description of study

The purpose of this observational study is to understand:

  • If patients are satisfied using GEMTESA ® (Vibegron);
  • What side effects (if any) they may experience using GEMTESA ® (Vibegron);
  • How GEMTESA ® (Vibegron) impacts their quality of life;
  • If they need any additional treatment for Overactive Bladder (OAB) besides GEMTESA® (Vibegron).

Clinical Study Identifier: s22-00558
Principal Investigator: Benjamin M. Brucker.
Other Investigator: Lauren E. Stewart.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.